These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

557 related items for PubMed ID: 28034069

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Racial differences in long-term adjuvant endocrine therapy adherence and mortality among Medicaid-insured breast cancer patients in Texas: Findings from TCR-Medicaid linked data.
    Farias AJ, Wu WH, Du XL.
    BMC Cancer; 2018 Dec 04; 18(1):1214. PubMed ID: 30514270
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The Association Between Out-of-Pocket Costs and Adherence to Adjuvant Endocrine Therapy Among Newly Diagnosed Breast Cancer Patients.
    Farias AJ, Hansen RN, Zeliadt SB, Ornelas IJ, Li CI, Thompson B.
    Am J Clin Oncol; 2018 Jul 04; 41(7):708-715. PubMed ID: 27893470
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Medicare D Subsidies and Racial Disparities in Persistence and Adherence With Hormonal Therapy.
    Biggers A, Shi Y, Charlson J, Smith EC, Smallwood AJ, Nattinger AB, Laud PW, Neuner JM.
    J Clin Oncol; 2016 Dec 20; 34(36):4398-4404. PubMed ID: 27998232
    [Abstract] [Full Text] [Related]

  • 8. Race and Patient-reported Symptoms in Adherence to Adjuvant Endocrine Therapy: A Report from the Women's Hormonal Initiation and Persistence Study.
    Sheppard VB, Sutton AL, Hurtado-de-Mendoza A, He J, Dahman B, Edmonds MC, Hackney MH, Tadesse MG.
    Cancer Epidemiol Biomarkers Prev; 2021 Apr 20; 30(4):699-709. PubMed ID: 33514603
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Racial Differences in Adjuvant Endocrine Therapy Use and Discontinuation in Association with Mortality among Medicare Breast Cancer Patients by Receptor Status.
    Farias AJ, Du XL.
    Cancer Epidemiol Biomarkers Prev; 2017 Aug 20; 26(8):1266-1275. PubMed ID: 28515111
    [Abstract] [Full Text] [Related]

  • 11. Adjuvant therapy use among Appalachian breast cancer survivors.
    Tan X, Marshall VD, Anderson RT, Donohoe J, Camacho F, Balkrishnan R.
    Medicine (Baltimore); 2015 Jul 20; 94(26):e1071. PubMed ID: 26131828
    [Abstract] [Full Text] [Related]

  • 12. Adherence to Adjuvant Endocrine Therapy in Insured Black and White Breast Cancer Survivors: Exploring Adherence Measures in Patient Data.
    Sheppard VB, He J, Sutton A, Cromwell L, Adunlin G, Salgado TM, Tolsma D, Trout M, Robinson BE, Edmonds MC, Bosworth HB, Tadesse MG.
    J Manag Care Spec Pharm; 2019 May 20; 25(5):578-586. PubMed ID: 31039059
    [Abstract] [Full Text] [Related]

  • 13. Factors influencing adherence to adjuvant endocrine therapy in breast cancer-treated women: using real-world data to inform a switch from acute to chronic disease management.
    Cavazza M, Banks H, Ercolanoni M, Cukaj G, Bianchi G, Capri G, Longo F.
    Breast Cancer Res Treat; 2020 Aug 20; 183(1):189-199. PubMed ID: 32591986
    [Abstract] [Full Text] [Related]

  • 14. Initiation and adherence to adjuvant endocrine therapy among urban, insured American Indian/Alaska Native breast cancer survivors.
    Emerson MA, Achacoso NS, Benefield HC, Troester MA, Habel LA.
    Cancer; 2021 Jun 01; 127(11):1847-1856. PubMed ID: 33620753
    [Abstract] [Full Text] [Related]

  • 15. Racial/Ethnic and gender gaps in the use of and adherence to evidence-based preventive therapies among elderly Medicare Part D beneficiaries after acute myocardial infarction.
    Lauffenburger JC, Robinson JG, Oramasionwu C, Fang G.
    Circulation; 2014 Feb 18; 129(7):754-63. PubMed ID: 24326988
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of the Quality of Adjuvant Endocrine Therapy Delivery for Breast Cancer Care in the United States.
    Daly B, Olopade OI, Hou N, Yao K, Winchester DJ, Huo D.
    JAMA Oncol; 2017 Jul 01; 3(7):928-935. PubMed ID: 28152150
    [Abstract] [Full Text] [Related]

  • 17. Disparities in Breast Cancer Survival by Socioeconomic Status Despite Medicare and Medicaid Insurance.
    Silber JH, Rosenbaum PR, Ross RN, Reiter JG, Niknam BA, Hill AS, Bongiorno DM, Shah SA, Hochman LL, Even-Shoshan O, Fox KR.
    Milbank Q; 2018 Dec 01; 96(4):706-754. PubMed ID: 30537364
    [Abstract] [Full Text] [Related]

  • 18. Racial and ethnic differences in outcomes in older patients with acute ischemic stroke.
    Qian F, Fonarow GC, Smith EE, Xian Y, Pan W, Hannan EL, Shaw BA, Glance LG, Peterson ED, Eapen ZJ, Hernandez AF, Schwamm LH, Bhatt DL.
    Circ Cardiovasc Qual Outcomes; 2013 May 01; 6(3):284-92. PubMed ID: 23680966
    [Abstract] [Full Text] [Related]

  • 19. Racial/ethnic differences in use and duration of adjuvant hormonal therapy for breast cancer in the women's health initiative.
    Livaudais JC, Lacroix A, Chlebowski RT, Li CI, Habel LA, Simon MS, Thompson B, Erwin DO, Hubbell FA, Coronado GD.
    Cancer Epidemiol Biomarkers Prev; 2013 Mar 01; 22(3):365-73. PubMed ID: 23275187
    [Abstract] [Full Text] [Related]

  • 20. Potential Health Implications of Medication Therapy Management Eligibility Criteria in the Patient Protection and Affordable Care Act Across Racial and Ethnic Groups.
    Wang J, Qiao Y, Shih YC, Jarrett-Jamison J, Spivey CA, Wan JY, White-Means SI, Dagogo-Jack S, Cushman WC, Chisholm-Burns M.
    J Manag Care Spec Pharm; 2015 Nov 01; 21(11):993-1003. PubMed ID: 26521111
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.